Affordable Access

deepdyve-link deepdyve-link
Publisher Website

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer.

Authors
  • Soysal, S D
  • Muenst, S
  • Barbie, T
  • Fleming, T
  • Gao, F
  • Spizzo, G
  • Oertli, D
  • Viehl, C T
  • Obermann, E C
  • Gillanders, W E
Type
Published Article
Journal
British Journal of Cancer
Publisher
Springer Nature
Publication Date
Apr 16, 2013
Volume
108
Issue
7
Pages
1480–1487
Identifiers
DOI: 10.1038/bjc.2013.80
PMID: 23519058
Source
Medline
License
Unknown

Abstract

The differential association of EpCAM expression with prognosis in intrinsic subtypes has important implications for the development of EpCAM-targeted therapies in breast cancer.

Report this publication

Statistics

Seen <100 times